Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8799 USD | +4.75% | +1.14% | +72.53% |
May. 06 | Oppenheimer Upgrades Chemomab Therapeutics to Outperform | MT |
Apr. 10 | Transcript : Chemomab Therapeutics Ltd. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+72.53% | 11.93M | |
+11.06% | 115B | |
+12.79% | 106B | |
-4.52% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-11.29% | 17.56B | |
-39.36% | 17.32B | |
+7.51% | 14.03B | |
+32.89% | 12.13B |
- Stock Market
- Equities
- CMMB Stock
- News Chemomab Therapeutics Ltd.
- Oppenheimer Adjusts Chemomab Therapeutics Price Target to $7 From $12, Maintains Outperform Rating